iRhythm Teams Up With BioIntelliSense, Expanding Ambulatory Cardiac Monitoring Capabilities
Author: Benzinga Newsdesk | September 04, 2024 07:37am
iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company has signed an exclusive license agreement with BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, to develop and commercialize certain patented technology assets within ambulatory cardiac monitoring (ACM).
Posted In: IRTC